Protocol Section
The Protocol Section is one of the main sections in ClinicalTrials.gov data structure. It contains protocol-related information for clinical trials, including identification, status, design, eligibility, and other key details about how the trial is structured and conducted.
Protocol Section path is as follows:
Study -> Protocol Section -> Protocol Modules (Identification, Status, Design, Eligibility, etc.)
Protocol Section
Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2025-12-24 @ 9:08 PM
NCT ID:
NCT03328104
Description:
Data related to patient diagnosis, toxicity and outcomes will be shared. Data will be available immediately following publication and will be shared with investigators who propose using the data after being approved by a review committee. Data will be available for the purpose of inclusion in meta-analysis by contacting the principal investigator at hsabnis@emory.edu, following which a data use agreement will be needed for sharing data.
Study:
NCT03328104
Study Brief:
Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma